How Amboss Became Market Leader in Medical Education and Is Heading Toward €100 Million Revenue

About this episode

Sievert Weiss, a trained physician, created something that millions of doctors worldwide use daily: Amboss, a learning software that accompanies medical professionals from their first day at university through specialized medical training and beyond. The startup already generates eight-figure revenues and is heading toward the €100 million mark.

From Physician to Entrepreneur

Why does a "qualified" doctor suddenly become an entrepreneur? During his studies and time as a physician, Sievert recognized a fundamental problem: while medical knowledge exists, it's often difficult to access and not optimally presented. Traditional textbooks are static, updates take years, and the flood of information in the medical field grows exponentially.

This is exactly where the idea for Amboss took root: creating a digital platform that doesn't just make medical knowledge available, but intelligently connects it, constantly updates it, and adapts it to different learning phases.

Amboss's Comprehensive Product Offering

Today, Amboss covers significantly more than just learning material for students. The platform offers:

• –Comprehensive reference work for all medical specialties
• –Exam preparation for various career stages
• –Continuing education modules for practicing physicians
• –Specialized content for specialist training
• –Mobile applications for clinical practice

Continuous expansion of the offering was part of the strategy from the beginning. "Did you realize from the start that you'd have to keep expanding your product offering?" – This question highlights a crucial point: successful platforms must grow with their users.

The Challenge of Product Diversity

With a broad product portfolio comes increased complexity. How do you prevent more options from making platform usage chaotic? Amboss solves this through intelligent personalization and clear user guidance. Each user primarily sees content relevant to their current situation.

The various membership models are strategically structured:

• –Basic access for students
• –Extended packages for exam candidates
• –Professional versions for practicing doctors
• –Institutional licenses for hospitals and universities

Time Budget: Internationalization vs. Product Development

One of the most critical decisions for growing startups is resource allocation. How much time and capital flows into internationalization versus new product features?

Sievert emphasizes that this balance must be constantly readjusted. While internationalization is important for growth, product quality cannot suffer. The key lies in developing both areas in parallel without fragmenting resources too heavily.

Investors and Extended Business Models

How did investors respond to the business idea and continuous product expansion? The reaction was mixed – while some immediately recognized the potential, others were skeptical about the complexity of a constantly expanding offering.

The challenge with VCs often lies in their preference for simple, scalable business models. A product that continuously evolves and targets different user groups can be perceived as riskier.

The Market Ultimately Decides

Despite all investor opinions and strategic considerations, the market ultimately determines success or failure. Amboss has proven that it's possible to successfully manage a complex, evolving product portfolio.

Product market fit must be continuously re-established. What works for students doesn't automatically work for practicing physicians. Each user group has specific needs that must be understood and served.

Lessons for Other Founders

Sievert's journey with Amboss demonstrates several important principles:

• –Real problems require thoughtful, not superficial solutions
• –Successful platforms must grow with their users
• –The balance between product development and internationalization is critical
• –Investor skepticism toward more complex models shouldn't be discouraging
• –The market is the ultimate judge of business models

Amboss today stands as an example of how concrete problem recognition can become market leadership – with the right combination of medical expertise, entrepreneurial thinking, and willingness to continuously learn and adapt.